Your browser doesn't support javascript.
loading
An Observational Prospective Cohort Study of Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection of an Aerosolized, Inhaled Adenovirus Type 5-Vectored Coronavirus Disease 2019 Vaccine Given as a Second Booster Dose in Guangzhou City, China.
Wang, Fu-Zhen; Zhang, Chun-Huan; Tang, Lin; Rodewald, Lance E; Wang, Wen; Liu, Si-Yu; Wang, Wen-Ji; Wu, Dan; Liu, Qian-Qian; Wang, Xiao-Qi; Huang, Li-Fang; Huang, Ao-Di; Bao, Li-Ming; Zhang, Zhou-Bin; Yin, Zun-Dong.
  • Wang FZ; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Zhang CH; Department of Immunization Program Planning, Guangzhou Center for Disease Control and Prevention, Guangzhou, China.
  • Tang L; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Rodewald LE; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Wang W; Department of Immunization Program Planning, Guangzhou Center for Disease Control and Prevention, Guangzhou, China.
  • Liu SY; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Wang WJ; Department of Immunization Program Planning, Guangzhou Center for Disease Control and Prevention, Guangzhou, China.
  • Wu D; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Liu QQ; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Wang XQ; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Huang LF; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Huang AD; Department of Immunization Program, Fujian Provincial Center for Disease Control and Prevention, Fuzhou, China.
  • Bao LM; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Zhang ZB; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Yin ZD; Department of Immunization Program Planning, Guangzhou Center for Disease Control and Prevention, Guangzhou, China.
J Infect Dis ; 229(1): 117-121, 2024 Jan 12.
Article en En | MEDLINE | ID: mdl-37565805
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Etiology_studies / Observational_studies Límite: Humans País como asunto: Asia Idioma: En Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Etiology_studies / Observational_studies Límite: Humans País como asunto: Asia Idioma: En Año: 2024 Tipo del documento: Article